Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Advanced Nanoparticle-Engineered Platforms for Peripheral Nerve Repair: Multimodal Therapeutic Strategies and Clinical Translation

Shi S., Yu X., Ou X., Zheng C., Xie F., Huang Y.

Narrative Review on Chronic Inflammation, Immune Modulation, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Int J Nanomedicine (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41058939
PMCID
PMC12499593
DOI
10.2147/ijn.s547018
Citations
1

Abstract (original English)

Peripheral nerve injuries (PNIs) remain a major clinical challenge, with current surgical interventions often falling short of restoring full function. Nanoparticle (NP)-engineered platforms are emerging as transformative tools in peripheral nerve repair by enabling multimodal therapeutic delivery, spatiotemporal control of the microenvironment, and biomimetic structural support. In this review, we summarize the recent advances in the design of inorganic, polymeric, and hybrid NPs that deliver neurotrophic factors, anti-inflammatory agents, and genetic material with high precision. Functionalization strategies-ranging from conductive and piezoelectric materials to antioxidant and immunomodulatory components-enable dynamic regulation of cellular behaviors critical for regeneration. Integration of NPs into next-generation scaffolds, including smart-responsive conduits and bioactive matrices, enhances axonal guidance and Schwann cell support. We further discuss preclinical outcomes demonstrating robust functional recovery and address translational barriers, including NP toxicity, scalable fabrication, and regulatory considerations. Finally, we outline future directions involving theranostic systems and AI-guided design for personalized nerve repair. Collectively, NP-engineered systems represent a paradigm shift in peripheral nerve regeneration, offering a multifaceted approach tha

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansNerve Growth FactorsAnti-Inflammatory AgentsCombined Modality TherapyNerve RegenerationNanoparticlesTissue ScaffoldsPeripheral Nerve InjuriesTheranostic Nanomedicine

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research